Drug targets are identified through techniques like genomics, proteomics, and bioinformatics, which help uncover disease-related proteins or genes. Validation involves confirming the target's role in disease and assessing its druggability through biochemical assays, genetic manipulation, and preclinical studies, ensuring it can be effectively modulated by a drug.